Publishing Guide

Getting Credit for Peer Review: What the 2026 Recognition Crisis Means for Medical Academics

Peer review has always been uncompensated labor. What has changed in 2026 is that researchers, journal editors, and at least some institutions are starting to argue that this arrangement is not sustainable and not fair. Here is what medical academics who review can do now to make the work visible.

MZ
Dr. Meng Zhao|Physician-Scientist · Founder, LabCat AI
Published: October 2026•16 min read•Publishing Guide

In early October 2026, the Journal of General Internal Medicine published a commentary by clinician-scientist Emma Tillman titled "How Much Peer Review Is Enough? Rethinking Scholarly Service in Academic Medicine." The argument was not new, but the framing was unusually direct: peer review is a workforce problem disguised as a cultural norm. Roughly 20 percent of active reviewers complete somewhere between 70 and 90 percent of all peer reviews in the biomedical literature. Those reviewers are doing this work in time borrowed from research, clinical duties, and teaching. Almost none of them are formally credited for it when promotion decisions are made.

The article ran in the same week that separate analyses were circulating on the estimated dollar value of peer review labor: approximately $1,272 per reviewer per year, and somewhere between $1.1 and $1.7 billion annually for the scientific community as a whole. Those figures come from a 2021 study in Research Integrity and Peer Review that estimated reviewer time costs based on survey data; the methodology has been debated, but the rough magnitude has not. The scientific publishing industry extracts enormous amounts of skilled labor from the researchers who are simultaneously its authors, its customers, and its quality-control workforce, without paying them for the reviewing portion.

Why This Matters in 2026

Submission volumes to major biomedical journals rose roughly 68 percent between 2018 and 2026, without a comparable increase in the reviewer pool. The concentrated workload among a minority of faculty is not a quirk of academic culture. It is a structural imbalance that has been growing for years, and it is now large enough that leading journals are struggling to find qualified reviewers for standard turnaround times.

If you are one of the faculty members doing ten, fifteen, or thirty reviews a year, this context matters to you in a practical way. The question is not whether peer review is valuable. It clearly is. The question is whether your institution sees it as valuable, and whether you have set up your workflow to make that visible. Most medical academics have not, and the gap between effort and recognition is now measurable and documented.

Where Peer Review Sits in Academic Medicine Promotion

Promotion decisions in academic medicine typically rest on three categories: research output, clinical productivity, and teaching. Peer review appears nowhere in any of those three, even though it is formally classified as scholarly service by most universities. The problem is that "service" is a catchall category that includes everything from sitting on departmental committees to organizing grand rounds, and it tends to be evaluated loosely if at all. A candidate who reviewed 40 manuscripts in a given year and a candidate who reviewed zero manuscripts are treated identically in most academic medicine promotion frameworks, because the documentation does not exist in a form that promotion committees can easily assess.

The Tillman commentary in JGIM is one of several 2026 pieces calling attention to this gap. A companion piece in the same journal noted that the absence of formal recognition may itself be part of what concentrates peer review among a small subset of faculty who feel a strong obligation to the scientific community, because those are often the same people who are conscientious about other unrewarded service. The system effectively relies on intrinsic motivation while removing the extrinsic signals that would distribute the work more evenly.

A June 2026 letter in the Indian Journal of Community Medicine made a specific proposal: create a credit system for peer review analogous to continuing medical education points, one that could feed into promotion and tenure applications. The argument is that CME credits exist precisely because the medical profession decided that professional development requires structured time allocation and formal recognition. Peer review represents a similar kind of professional investment, and treating it the same way would give institutions a concrete mechanism for rewarding it.

No major academic medical center had formally adopted such a policy as of early October 2026, as far as available reporting indicates. But the conversation is now louder and better-documented than it was even two years ago.

Tracking Your Reviews: ORCID and Web of Science Researcher Profile

The first practical step for any researcher who reviews regularly is to build a documented record. Two platforms exist specifically for this purpose, and neither requires your institution to have adopted any formal credit policy.

ORCID, the Open Researcher and Contributor ID system, includes a peer review section in every researcher profile. When a journal that participates in ORCID's reviewer credit system receives and processes your review, it can push a verified record directly to your ORCID profile. The record shows the journal name and the date of the review, but not the manuscript title or any identifying information about the authors, because the review remains confidential. Your ORCID profile can then be linked from your CV, your institution's faculty page, and any grant or promotion application that accepts external profile links. Several publishers, including the American Chemical Society, now automatically send review records to reviewer ORCID profiles after a manuscript decision is reached.

The second platform is the Web of Science Researcher Profile, which absorbed Publons after Clarivate acquired Publons in 2017 and merged the products in 2022. Publons was originally designed to provide exactly this kind of verified review documentation, and its core functionality carried over into the Web of Science integration. If you already had a Publons profile, your review history migrated automatically. If you are starting fresh, you can create a Web of Science Researcher Profile and connect it to your ORCID record so that review credits documented on one platform appear on the other. Some journals and publishers route reviewer acknowledgment specifically through the Web of Science system rather than ORCID directly, so having both set up is worth the small additional effort.

What these platforms can and cannot do

Both ORCID and Web of Science Researcher Profile verify that you completed a review for a given journal at a given time. They confirm volume, breadth across journals, and tenure of service. They cannot confirm the quality of the review, the significance of the manuscripts you were invited to review, or how your reviewing compares to peers at other institutions. Those judgments still require a cover letter explanation or a letter of support from an editor who knows your work.

The profile is evidence, not argument. You still need to make the case for why the reviewing matters for your scholarly contribution.

Not all journals participate in automatic credit routing to ORCID. For reviews completed at journals that do not, ORCID allows you to add review records manually, though these are not independently verified. If you are building a promotion dossier, verified records carry more weight than self-reported ones, so it is worth checking whether the journals you review for have ORCID integration and, if not, whether you can request that they add it.

CME Credit for Peer Review: What Is Available Right Now

A more immediately tangible benefit is continuing medical education credit. Several publishers already offer AMA PRA Category 1 Credits to physicians who complete peer reviews for their journals, and the ACCME allows up to 15 AMA PRA Category 1 Credits per year to be claimed through peer review activity.

Wiley runs CME-for-reviewers programs across a range of medical specialty titles. For journals that participate, reviewers may claim 3.0 AMA PRA Category 1 Credits for each original manuscript reviewed, with additional review rounds for the same manuscript not earning additional credit. The Journal of the American Geriatrics Society and several other Wiley medical titles operate this program. ASCO Journals evaluates each submitted review for CME eligibility, with the journal's editor determining whether a review meets the threshold. The Journal of Clinical Psychiatry has structured its peer review as a formal 2026 CME activity offering 3.00 credits per activity, with the full 15-credit annual ACCME limit available to active reviewers across multiple activities.

This is not universal. Many journals, including some with high impact factors, do not offer CME credit for review. The journals most likely to have it are those published through large commercial or society publishers that have invested in the accreditation infrastructure. If CME credit matters to you for licensure maintenance or institutional reporting, it is worth checking this directly with the journal before you accept a review invitation. The relevant question to ask an editorial office is whether the journal's peer review activity is ACCME-accredited, and if so, what the instructions are for claiming credit after you submit.

The June 2026 commentary in the Indian Journal of Community Medicine urged caution about monetary incentives specifically, noting that payment for reviews can shift reviewers' motivation in ways that may not benefit the quality of the scientific record. CME credit sits differently in that argument, because it is a professional development benefit rather than direct payment, and its value to any individual reviewer depends on whether they need the credits. For clinician-scientists who maintain active medical licenses, it has concrete utility. For researchers without clinical duties, it may matter less.

Writing Peer Review Into Your Promotion Dossier

Most promotion guidelines at academic medical centers include a service section and ask candidates to describe their contributions to the scientific community. This is where peer review belongs, and most candidates either underreport it or describe it too generically to be legible.

The format that tends to be most useful for promotion committees is a simple table: journal name, number of reviews in each year, whether you hold a standing editorial board appointment, and any recognition received from the journal such as top reviewer status or acknowledgment in an annual issue. Some journals publish annual lists of reviewers in a dedicated issue; if you appear on those lists, note them explicitly. They are third-party attestations that carry more weight than a self-reported total.

If you are an editorial board member, that appointment belongs in the section on professional recognition, not just in the service section. Board membership is by invitation and reflects a journal's active decision to associate your name with its quality signal. That is meaningfully different from ad hoc reviewing, and promotion committees understand the distinction.

A practical framing for the service section

Ad hoc peer review: 2022 (8 reviews), 2023 (12 reviews), 2024 (15 reviews), 2025 (18 reviews). Journals include the New England Journal of Medicine (1), JAMA Internal Medicine (3), Annals of Internal Medicine (4), BMJ (2), and others. Verified review records available on ORCID [link].

This format gives the committee a total, a trend, a sense of journal selectivity, and a pointer to an independently verified record. It is more useful than "served as a reviewer for several high-impact journals."

Some candidates worry that listing review activity in detail will appear to be padding the CV. It is not. A promotion committee that sees 53 verified peer reviews over four years at selective journals is looking at evidence of field recognition (you were invited) and sustained scientific citizenship (you accepted and completed). Those are legitimate scholarly contributions. The concern about padding comes from listing activities that do not require expertise or that are not independently verifiable. Peer review is both.

What Journals Are Doing to Recognize Reviewers

Publishers have become increasingly aware that the reviewer shortage and the recognition problem are connected. A number of formal recognition programs now exist, and being aware of them helps you capture whatever benefit is available.

Springer Nature runs an Editor of Distinction award program that was active in 2026 and specifically recognized editors and reviewers for contributions to maintaining scientific standards. While this is primarily a recognition for editors, several awards went to researchers recognized for exceptional reviewing contributions. The American Journal of Neuroradiology has a longstanding partnership with the Web of Science Researcher Profile system to give reviewers credit. Nature Portfolio journals have built opt-in reviewing acknowledgment directly into their editorial workflow, so reviewers who want credit to appear on their public profiles can enable it.

Some journals publish annual acknowledgment sections listing everyone who reviewed for them in the preceding year. If the journals you review for do this, keep a copy of those issues. A PDF or URL showing your name in the published acknowledgment is a primary source you can attach to a grant application or tenure file.

Several society journals in clinical medicine have started offering nonmonetary perks to frequent reviewers: complimentary access to the journal's archives, discounts on article processing charges for authors who are also active reviewers, and priority consideration for review invitations on topics adjacent to their own research area. None of these are career-defining benefits, but they reflect a shift in how publishers are thinking about reviewer retention as the shortage deepens.

The Debate About Paying Reviewers

No survey of peer review recognition in 2026 is complete without addressing the payment question. A November 2025 KevinMD piece titled "Stop Doing Peer Reviews for Free" made the argument plainly: publishers profit from researcher labor, and the asymmetry has become hard to justify. Similar arguments have appeared in the British Medical Journal, Nature, and a range of advocacy contexts over the past few years.

The counterargument, reflected in the Indian Journal of Community Medicine commentary cited earlier, is that payment introduces perverse incentives. If reviewers are paid per review, they may accept invitations they are not well-qualified for. If payment varies by journal or by manuscript type, it shapes which manuscripts get reviewed quickly and which wait. The independence of the review process depends partly on reviewers having no financial stake in the outcome, and that independence is worth protecting.

The current consensus, such as it is, favors nonmonetary recognition over direct payment. CME credits, ORCID documentation, acknowledgment programs, and institutional service credit are all mechanisms that give reviewers something real without creating a payment market. Whether that consensus will hold as the shortage deepens is genuinely uncertain. A few smaller publishers have experimented with token payments in the range of $50 to $100 per review; none of the major medical publishers had followed as of the time of writing.

Protecting Your Reviewing Time

The practical question for any active reviewer is not just how to get credit, but how to manage the load without it consuming the protected research time that actually drives promotion. The concentration problem identified in the Tillman commentary describes what happens when there is no structure around reviewing: the people most likely to accept invitations end up with an unsustainable volume, while their departments treat the work as invisible overhead.

A useful heuristic that circulates informally in academic medicine is the reciprocity principle: aim to review roughly as many papers as you submit for review each year. If you submit four papers in a given year, completing eight to twelve reviews is reasonable and sustainable. More than that, and you are subsidizing the rest of the system at the expense of your own productivity. The principle is not a formal policy anywhere, but it gives you a defensible internal limit when you are deciding whether to accept another invitation.

When you do decline an invitation, many journals now offer a mechanism to suggest an alternative reviewer. Using this option when you decline is a form of community contribution that costs little time and helps the journal. Some editorial systems track whether suggested alternatives were actually contacted, but the gesture is separate from whether the suggestion was used. It maintains goodwill with editors who will invite you again for manuscripts that better match your expertise.

What Might Change, and How Quickly

The JGIM commentary and its companion pieces in October 2026 are part of a conversation that has been building. But commentary in medical journals does not translate quickly into institutional policy change. Academic medicine promotion frameworks are set at the departmental and divisional level, reviewed infrequently, and typically require multi-year committee processes to revise. A proposal floated in a general internal medicine journal in October 2026 will not appear in most promotion guidelines by 2027.

What is more likely to move faster is the tooling. ORCID adoption among journals is expanding steadily, and the barrier to adding peer review credit routing is low for publishers already integrated with the ORCID API. Within two to three years, it is plausible that most major biomedical publishers will route verified review records to ORCID automatically, regardless of whether institutions have changed how they weight peer review in promotion. Once the records exist at scale, the argument for counting them in promotion decisions becomes much easier to make with data.

The recognition gap will not close on its own. But the infrastructure for closing it is available now, and researchers who start using it today will be better positioned than those who wait for institutions to lead.

A Starting Point for Active Reviewers

If you are actively reviewing manuscripts but have not yet set up the documentation infrastructure, the minimum useful steps are straightforward. Create or update an ORCID profile and make sure your email address in the editorial management systems you use (ScholarOne, Editorial Manager, Reviewers' Central) matches your registered ORCID email. Enable the peer review notification option in ORCID so that your profile receives automatic credit pushes from participating journals.

Create a Web of Science Researcher Profile and link it to your ORCID record. If you had a Publons account before 2022, check that the migration captured your complete history, because some older records required manual confirmation during the transition.

Add a peer review section to your CV and populate it now, before your next promotion or grant application. Use specific journal names and annual totals rather than generic language. If any of the journals you review for participate in the Wiley CME program, ASCO's CME program, or similar offerings, claim the credits in the cycle in which the review was completed rather than accumulating a backlog.

None of this is complicated. What it requires is treating your reviewing work with the same administrative attention you give to your publications. The scientific community asks a great deal of its peer reviewers, and the least you can do for yourself is make sure the record reflects what you have actually done.

Further Reading

MZ

Written by Dr. Meng Zhao

Physician-Scientist · Founder, LabCat AI

MD · Former Neurosurgeon · Medical AI Researcher

Dr. Meng Zhao is a former neurosurgeon turned medical-AI researcher. After years in the operating room, he moved into applied AI for clinical workflows and now leads LabCat AI, a medical-AI company working on decision support and research tooling for clinicians. He built Journal Metrics as a free resource for researchers who need reliable journal metrics without paid database subscriptions.

Related Articles